Profile Picture
Rewards
  • All
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Throat cancer battle
'People are dying’
US 'won't tolerate'
Perform ‘Karma’ live
1st show in 20 years
A green Grand Canal
Coca-Cola 600 delayed
Swims to the top
George Maharis dies
Families seek justice
NK infant jailed
Lukashenko in hospital
Commencement speech
Ceasefire deal
Rico in intensive care
Defends debt deal
First domestic plane
Marta Kostyuk booed
Broke voting record
Tribal militants dead
Wins Indy 500
Escaped inmate dead
US lawyer uses ChatGPT
Martins narrow escape
Oman's Sultan in Iran
Pentecost celebration
Tourist boat overturns
Release debt deal text
Wins Giro d'Italia
Atl. teen shot, dead
Iran sanctions bill
Celebrity extravaganza
96-yr-old sets record
Wins LIV Golf DC event
Returns from lymphoma
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
17,900 results
Hosted on MSN3mon
Amgen lays off 300, does not disclose whether any are in Thousand Oaks
Amgen is the latest big company to cut its workforce, with a recent restructuring that led to about 300 layoffs, the Thousand Oaks-based biotech company said Monday. Amgen has about 24,000 ...
The Motley Fool25d
Why Amgen Stock Was Sickly Today
This is uncomfortable for Amgen and its shareholders as the company announced last December that it would acquire Horizon. Not only that, but the suitor had said it would pay a premium of nearly ...
2don MSN
Dow Jones Today: Index Up on Debt Ceiling Hopes
The Dow Jones Industrial Average rose 1.1%, or 350 points, breaking its weeklong losing streak as negotiators in Washington ...
Benefits Pro6d
Sanofi wins Supreme Court cholesterol drug dispute with Amgen
Amgen had sought to collect millions in damages from Sanofi because the pharmaceutical company makes a rival drug called ...
Seeking Alpha1mon
Amgen 2023 revenue, earnings outlook include consensus estimates
Amgen's (NASDAQ:AMGN) full-year 2023 revenue and EPS outlook ranges both include the consensus estimates. The biotech giant is guiding toward revenue between $26.2B and $27.3B ($26.72B consensus ...
Hosted on MSN9d
5 Things to Know Before Markets Open
It ends patent infringement lawsuits that Amgen had brought against Sanofi ... a February announcement that the company would ...
Nasdaq1mon
US Amgen ruling keeps generic psoriasis drug off market until 2028
April 19 (Reuters) - Amgen Inc AMGN.O convinced a U.S. appeals court on Wednesday to uphold patents that bar generic versions of its blockbuster psoriasis drug Otezla proposed by Zydus ...
12d
Amgen Deal Faces Off With FTC
Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories.
Wall Street Journal5d
Amgen Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Reuters26d
Amgen sues Novartis to block generic osteoporosis, bone cancer drugs
Novartis, which is also named in the complaint, is preparing to spin Sandoz off into a standalone company later this year. Amgen's Prolia is used to treat osteoporosis. Xgeva, with the same active ...
CoinDesk1mon
Crypto Lender Genesis Lays Off 30% More of Its Staff
Genesis Global Trading laid off more employees on Thursday, a spokesperson for the crypto-trading firm confirmed in a statement to CoinDesk. A person familiar with the matter said Genesis ...
TechCrunch16d
Autonomous delivery startup Nuro to lay off 30% of workforce
Autonomous delivery robot startup Nuro will lay off 30%, or about 340 employees, across the company as part of a restructuring meant to extend its capital runway, according to the company.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback